A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results

Leticia Krauss-Silva, Maria Elizabeth L Moreira, Mariane B Alves, Alcione Braga, Karla G Camacho, Maria Rosa R Batista, Antonio Almada-Horta, Maria R Rebello, Fernando Guerra, Leticia Krauss-Silva, Maria Elizabeth L Moreira, Mariane B Alves, Alcione Braga, Karla G Camacho, Maria Rosa R Batista, Antonio Almada-Horta, Maria R Rebello, Fernando Guerra

Abstract

Background: Bacterial vaginosis increases the risk of spontaneous preterm delivery at less than 34 weeks of gestation.

Objective: The purpose of this study was to evaluate the efficacy of the early administration of selected lactobacilli strains (probiotics) to pregnant women with asymptomatic bacterial vaginosis/intermediate-degree infections to prevent spontaneous premature delivery and associated neonatal morbidity.

Methods/design: Asymptomatic pregnant women at less than 20 weeks of gestation, with no indication of elective preterm delivery, with a vaginal pH ≥ 4.5 and Nugent score > 3 were randomly assigned to the placebo or intervention group (oral administration of selected lactobacilli up to the 24th to 26th week of gestation). The randomisation was stratified for the history of premature delivery (HPD) and blocked. The allocation was concealed, and the participating health professionals and patients were blinded. The primary outcome was preterm delivery (<34 to <32 weeks), and the secondary outcomes were associated neonatal complications.

Results: In total, 4,204 pregnant women were screened; 320 and 324 individuals were respectively randomly assigned to the placebo and intervention groups, and 62% finished the trial. None of the randomised patients were lost to follow-up. For the non-HPD stratum, the intent-to-treat relative risks of spontaneous premature birth at < 34 and < 37 weeks' gestation were 0.33 (0.03, 3.16) and 0.49 (0.17, 1.44), respectively, and they were non-significant (ns) with p = 0.31 and 0.14. The corresponding actual treatment figures were zero and 0.32 (0.09, 1.19), which were ns with p = 0.12 and 0.06. The intent-to-treat relative risk of spontaneous premature birth at < 37 weeks of gestation for the trial as a whole, including HPD and non-HPD participants, was 0.69 (0.26, 1.78), p = 0.30 (ns). The neonatal complications under evaluation occurred in only one infant (< 34 weeks; placebo group) who presented with respiratory distress syndrome and suspected early neonatal sepsis. The recorded adverse events were minor and relatively non-specific.

Conclusions: The efficacy of the tested probiotics to prevent preterm delivery among women without a history of preterm delivery was not determined because the study sample was insufficient to estimate statistically significant intent-to-treat effects; additional studies are needed to evaluate this intervention among these women.

Trial registration: Trial registration at NIH register: NCT00303082. Sources of funding: the Brazilian Health Ministry and the State of Rio de Janeiro Research Foundation.

Figures

Figure 1
Figure 1
Observed flow of patients in the trial. * Returned all capsules (lack of adherence), unknown reason. ** Returned all capsules (unknown reason) (3), family opposed participation in the trial (1), pregnant woman suffered abortion (1), participant presented with UTI (1); the last two events occurred on the day that they were randomly assigned. *** Randomisation error (3): Nugent score < 4 (2); gestational age miscalculation (1). **** Randomisation error (1): Nugent score < 4.

References

    1. Agency for Healthcare Research and Quality. Management of preterm labor. Evidence report/technology assessment n. 18, AHRQ public n. 01-E021. 2000.
    1. Leal MC, Gama SGN, Campos MR. Fatores associados à morbi-mortalidade perinatal em uma amostra de maternidades públicas e privadas do município do Rio de Janeiro, 1999-2001. Cadernos de Saúde Pública. 2004;20(Supl 1):S20–S33.
    1. Campos MR, Leal MC, Souza PR Jr, Cunha CB. Consistência entre fontes de dados e confiabilidade inter-observador do estudo da morbi-mortalidade e atenção peri e neonatal no município do Rio de Janeiro. Cadernos de Saúde Pública. 2004;20(Supl 1):S34–S43.
    1. Berkowitz GS, Prince CB, Lapinski RH. Risk factors for preterm birth subtypes. Epidemiology. 1998;9(3):279–285. doi: 10.1097/00001648-199805000-00011.
    1. Goldenberg RL, Andrews WW, Hauth JC. Choriodecidual infection and preterm birth. Nutrition Reviews. 2002;60(5):S19–S25. doi: 10.1301/00296640260130696.
    1. Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infections and prematurity and the role of preventive strategies. Semin Neonatol. 2002;7:259–274.
    1. Goldenberg RL, Iams JD, Mercer BM, Meis P, Moawad A, Das A, Copper R, Johnson F. for the national Institute of Child Health and Human Development Network. What we have learned about the predictors of preterm birth. Seminars in Perinatology. 2003;27(3):185–93. doi: 10.1016/S0146-0005(03)00017-X.
    1. Mercer BM, Goldenberg RL, Das A. The preterm prediction study: A clinical risk assessment system. Am J Obstet Gynecol. 1996;174(6):1885–1895. doi: 10.1016/S0002-9378(96)70225-9.
    1. Klebanoff MA, Hauth JC, MacPherson CA, Carey JC, Heine RP, Wapner RJ, Iams JD, Moawad A, Miodovnik M, Sibai BM, van Dorsten JP, Dombrowski MP. for the National Institute for Child Health and Development Maternal Fetal Medicine Units Network. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. American Journal of Obstetrics and Gynecology. 2004;190(2):363–70. doi: 10.1016/j.ajog.2003.08.020.
    1. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Jun JK. The relationships among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000;183(5):1124–9. doi: 10.1067/mob.2000.109035.
    1. Yoon BH, Romero R, Kim KS. Transactions of the nineteenth annual meeting of the society for maternal-fetal medicine. Am J Obstet Gynecol. 1999;181(4):773–9. doi: 10.1016/S0002-9378(99)70299-1.
    1. Yoon BH, Romero R, Yang SH. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol. 1996;174(5):1433–40. doi: 10.1016/S0002-9378(96)70585-9.
    1. Gomez R, Romero R, Ghezzi F. The Fetal Inflammatory Response Syndrome. Am J Obstet Gynecol. 1998;179(1):194–202. doi: 10.1016/S0002-9378(98)70272-8.
    1. Cauci S. Vaginal Immunity in Bacterial Vaginosis. Current Infectious Disease Reports. 2004;6(6):450–6. doi: 10.1007/s11908-004-0064-8.
    1. McGregor JÁ, French JI, Richter R. Cervicovaginal microflora and pregnancy outcome: results of double-blind, placebo-controlled trial of erythromycin. Am J Obstet Gynecol. 1990;163(5 Pt 1):1580–91.
    1. Hauth JC, Goldenberg RL, Andrews WW. Reduced Incidence of Preterm Delivery With Metronidazole and Erythromycin in Women with Bacterial Vaginosis. N Engl J Med. 1995;333(26):1732–6. doi: 10.1056/NEJM199512283332603.
    1. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, Wapner R, Varner M, Trout W, Moawad A, Sibai BM, Miodovnik M, Dombrowski M, O'Sullivan MJ, van Dorsten JP, Langer O, Roberts J. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal and Fetal Medicine Units. N Engl J Med. 2000;343(8):534–40.
    1. Andrews WW, Sibai BM, Thom EA, Dudley D, Ernest JM, McNellis D, Leveno KJ, Wapmer R, Moawad A, O'Sullivan MJ, Caritis SN, Iams JD, Langer O, Miodovnik M, Dombrowski M. for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol. 2003;101(5):847–55. doi: 10.1016/S0029-7844(03)00172-8.
    1. Simhan HN, Caritis SN, Krohn MA, Tejada BM, Landers DV, Hillier SL. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol. 2003;189(2):560–7. doi: 10.1067/S0002-9378(03)00518-0.
    1. Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G. Bacterial Vaginosis. The inflammatory response and the preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol. 2004;190(6):1509–19. doi: 10.1016/j.ajog.2004.01.002.
    1. Klein LL, Gibbs R. Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol. 2004;190:1493–502. doi: 10.1016/j.ajog.2004.03.014.
    1. Isolauri E, Salminen S, Ouwehand AC. Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol. 2004;18(2):299–313. doi: 10.1016/j.bpg.2003.10.006.
    1. Vrese M, Schrezenmeir J. Probiotics and non-intestinal infectious conditions. Br J Nutr. 2002;88(Suppl 1):S59–S66.
    1. Reid G, Devillard E. Probiotics for mother and child. J Clin Gastroenterol. 2004;38(Suppl 2):S94–S101.
    1. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol. 2003;189(4):1202–8. doi: 10.1067/S0002-9378(03)00495-2.
    1. Reid G, Charbonneau D, Erb J, Beuerman D, Poehner R, Bruce AW. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbio. 2003;35:131–4. doi: 10.1016/S0928-8244(02)00465-0.
    1. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbio. 2001;32:37–41. doi: 10.1111/j.1574-695X.2001.tb00531.x.
    1. Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis. 2001;183(Suppl 1):S77–80.
    1. Reid G, Bruce AW, Fraser N. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbio. 2001;30:49–52. doi: 10.1111/j.1574-695X.2001.tb01549.x.
    1. Shalev E. Ingestion of probiotics: Optional treatment of bacterial vaginosis in pregnancy. IMAJ. 2002;4:357–60.
    1. Krauss-Silva, Reproductive Health. 2010. p. 14.
    1. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiology. 1991;29(2):297–301.
    1. Vermont Oxford Network. Database Manual of Operations. >Release 5.0.Burlington, VT. 2000.
    1. Altman DG, Schulz KF, Moher D, Egger M. et al.The Revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663–694.
    1. Moher D, Hopewell S, Schulz KF, Montori V, CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomized trials. BMJ. 2010. p. 340.
    1. Schulz KF, Altman DG, Moher D. for the CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials. Trials. 2010;11:32. doi: 10.1186/1745-6215-11-32.
    1. Meis PJ, Goldenberg RL, Mercer B. et al.The Preterm Prediction Study: significance of vaginal infections. Am J Obst Gynecol. 1995;173:1231–5. doi: 10.1016/0002-9378(95)91360-2.
    1. Hauth JC, Macpherson C, Carey JC, Klebanoff MA, Hillier SL, Ernest JM, Leveno KJ, Wapner R, Varner M, Trout W, Moawad A, Sibai BM. for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Early pregnancy threshold vagina pH and gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol. 2003;188(3):831–5. doi: 10.1067/mob.2003.184.
    1. Simhan HN, Caritis NS, Krohn MA, Hillier SL. Elevated Vaginal pH And Neutrophils Are Associated Strongly with Early Spontaneous Preterm Birth. Am J Obstet Gynecol. 2003;189(4):1150–4. doi: 10.1067/S0002-9378(03)00582-9.
    1. Monga M, Blanco J. Intrauterine Infection and Preterm Labor. Inf Dis Obstet Gynecol. 1995;3:37–44. doi: 10.1155/S1064744995000287.
    1. Mercer BM. Preterm Premature Rupture of Membranes. Obstet Gynecol. 2003;101:178–193. doi: 10.1016/S0029-7844(02)02366-9.
    1. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet and Gynecol. 1998;179(10):186–93.
    1. Goldenberg R, Culhane JF, Iams J, Romero R. Epidemiology and causes of preterm birth. The Lancet. 2008;371:75–84. doi: 10.1016/S0140-6736(08)60074-4.
    1. Cloherty JP, Eichenwald EC, Stark AR. Manual of Neonatal Care. Lippincott Williams & Wilkins; Fifth edition, Philadelphia; 2004.
    1. Pahlson C, Larsson PG. The ecologically wrong vaginal lactobacilli. Medical Hypotheses. 1991;36:126–130. doi: 10.1016/0306-9877(91)90253-U.
    1. Famularo G, Pieluigi M, Coccia R, Mastroiacovo P, De Simone C. Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med Hypotheses. 2001;56(4):421–30. doi: 10.1054/mehy.2000.1195.
    1. McLean NW, Rosenstein IJ. Characterization and selection of a Lactobacillus species to recolonize the vagina of women with recurrent bacterial vaginosis. J Med Microbiol. 2000;49:543–52.
    1. Iams JD, Goldenberg RL, Mercer BM, Moawad A, Das AF, Caritis SN, Miodovnik M, Menard MK, Thurnau GR, Dombrowski M, Roberts J. for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. The Preterm Prediction Study: Can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol. 2001;184(4):652–655. doi: 10.1067/mob.2001.111248.
    1. Genc MR, Witkin SS, Delaney ML, Paraskevas LR, Tuomala RE, Norwitz ER, Onderdonk AB. A disproportionate increase in IL-1B over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstetrics Gynecology. 2004;190(5):1191–1197.
    1. Kalinka J, Sobala W, Wasiela M, Brzezinska-Błaszczyk E. Decreased proinflammatory cytokines in cervicovaginal fluid, as measured in midgestation, are associated with preterm delivery. AJRI. 2005;54:70–76.
    1. Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A. Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol. 2002;110(4):617–23. doi: 10.1067/mai.2002.128528.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi